Download MendeleyFragment-Based Screening of NSD2-PWWP1 Identifies Novel Covalent Allosteric Ligands That Diminish Methyllysine and DNA Binding Abilities of NSD2.
Huang, Y., Li, Y., Chen, X., Wang, H., Wang, Q., Liu, S., Li, Y., Chen, Z., Ma, J., Huang, Z., Wan, J., Ren, Y., Min, J.(2025) J Med Chem 68: 24953-24967
- PubMed: 41264880
- DOI: https://doi.org/10.1021/acs.jmedchem.5c01902
- Primary Citation of Related Structures:
9KN9, 9KNA, 9KNB - PubMed Abstract:
The PWWP1 domain of NSD2 recognizes both H3K36me2/3 and DNA, a function critical for its subcellular localization and oncogenic activity, making it a promising therapeutic target. In this study, through fragment library screening and structure-activity relationship studies, we identified compounds that covalently bind to the C294 residue of NSD2-PWWP1. Structural and biochemical analyses demonstrated that compounds 13 and 16 competitively block NSD2-PWWP1's recognition of both H3K36me2 and DNA, thereby impairing its nucleosome-binding ability. This study uncovers a novel allosteric regulatory mechanism and provides a structural framework for the development of more effective cancer therapeutics targeting NSD2-PWWP1.
- Key Laboratory of Pesticide and Chemical Biology of Ministry of Education, Hubei Key Laboratory of Genetic Regulation and Integrative Biology, School of Life Sciences, Central China Normal University, Wuhan 430079, China.
Organizational Affiliation:
